Ranbaxy Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 14	Dec ' 12	Dec ' 11	Dec ' 10	Dec ' 09

Profit before tax

-848.43

-164.28

-3,048.67

1,565.25

1,061.92

Net cashflow-operating activity

-1,217.10

641.24

128.38

1,168.89

-665.43

Net cash used in investing activity

922.04

-1,670.89

1,765.14

-2,067.80

86.12

Netcash used in fin. activity

717.28

314.55

-1,275.14

991.48

-214.14

Net inc/dec in cash and equivlnt

421.36

-714.62

619.36

92.57

-793.46

Cash and equivalnt begin of year

66.57

781.19

161.83

69.26

862.39

Cash and equivalnt end of year

487.93

66.57

781.19

161.83

68.93